| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |